These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7306376)

  • 1. [Experience with the organization of drug information in Hungary (author's transl)].
    Zalai K; Gesztes L; Stenszky E
    Pharmazie; 1981 Jun; 36(6):438-9. PubMed ID: 7306376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Newly-developed drug information services provided by hospital pharmacists].
    Hirota Y
    Rinsho Byori; 2003 Apr; 51(4):341-6. PubMed ID: 12747257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the activities of the Information Service of the National Institute for Drug Control].
    Müllerová H; Vlcek J; Smíd M
    Ceska Slov Farm; 1998 May; 47(3):134-7. PubMed ID: 9650371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in the development of information systems at the canton level].
    Beslagić Z; Pasić A
    Med Arh; 1999; 53(3 Suppl 3):31-3. PubMed ID: 10870621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Computerization and the importance of information in health system, as in health care resources registry].
    Troselj M; Fanton D
    Acta Med Croatica; 2005; 59(3):251-7. PubMed ID: 16095200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Professional and social responsibilities of clinical pharmacology].
    Banić B; Stanulović M; Daković-Svajcer K; Jakovljević V; Mikov M; Sabo A; Popović J
    Med Pregl; 1997; 50(11-12):451-6. PubMed ID: 9471502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuropsychiatric pharmacists.
    Cohen LJ
    J Clin Psychiatry; 1999; 60 Suppl 19():54-7; discussion 58. PubMed ID: 10507281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statewide decentralized public drug information system.
    Montagne M; Clute SS; McKennell T
    Am J Hosp Pharm; 1980 Sep; 37(9):1211-5. PubMed ID: 7416176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and evaluation of pharmacists' commonly used drug information sources.
    Wong PS; Ko Y; Sklar GE
    Ann Pharmacother; 2009 Feb; 43(2):347-52. PubMed ID: 19193588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer.
    Boyland JI
    Hosp Pharm; 1983 Apr; 18(4):211-3, 216. PubMed ID: 10260207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The "pharmaceutical chain", important asset of health safety in France. Synthesis of the session].
    Santini C
    Ann Pharm Fr; 2008; 66(5-6):e9-12. PubMed ID: 19061724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety information project on drug, food and chemicals. Division of Safety Information on Drug, Food and Chemicals. National Institute of Health Sciences].
    Morikawa K; Yamamoto M; Nakano T; Kasuga F; Yamamoto M
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2003; (121):1-11. PubMed ID: 14740398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of risk management and risk assessment information: the role of the pharmacist.
    Schommer JC; Pedersen CA; Worley MM; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL; Chewning BA
    Res Social Adm Pharm; 2006 Dec; 2(4):458-78. PubMed ID: 17161806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals.
    Isetts BJ; Brown LM; Schondelmeyer SW; Lenarz LA
    Arch Intern Med; 2003 Aug 11-25; 163(15):1813-20. PubMed ID: 12912717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.